Moderna Inc. shares declined as the company’s cost-cutting efforts failed to assuage investors who are worried about the decline of its COVID vaccine business.
Moderna falls as cost-cutting fails to appease investors
view original post
Moderna Inc. shares declined as the company’s cost-cutting efforts failed to assuage investors who are worried about the decline of its COVID vaccine business.